Skip to content

SimulCareII

by Xanacare Technologies, LLC

SimulCareII is a Class II device made by Xanacare Technologies, LLC, listed in FDA GUDID since 20 Jan 2017 (UDI-DI B495SIMULCAREII0), registry data as of 31 May 2026.

Listed FDA GUDID listing, no authorization on record

Valid until

Not applicable

Database listing, no authorization

FDA recalls

Not checked

No FDA submission to match recalls against

Documents

None

No authorization documents

Trust

Unverified

Source GUDID, synced 31 May 2026.

Regulatory status

as of registry sync 31 May 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing NumberB495SIMULCAREII0 UDI-DI Date20 Jan 2017ListedStatusListed GUDID: in commercial distribution

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — GUDID listing Listed

Specification

GUDID

Generic name
Transcutaneous electrical stimulation probe
Model / reference
SimulCareII
Primary DI / UDI-DI
B495SIMULCAREII0
FDA product code
GZJ
GMDN term
Transcutaneous electrical stimulation probe
Device class
Class II
Regulation number
882.5890
GUDID distribution status
In Commercial Distribution

Similar devices

Other devices filed under FDA product code GZJ (Stimulator, Nerve, Transcutaneous, For Pain Relief).

Other devices from Xanacare Technologies, LLC

Properties

  • Prescription use
  • Convenience kit
  • Serial number
Other properties (12, all answered No)